DE60133377D1 - Dezellularisierte gefässprothesen - Google Patents

Dezellularisierte gefässprothesen

Info

Publication number
DE60133377D1
DE60133377D1 DE60133377T DE60133377T DE60133377D1 DE 60133377 D1 DE60133377 D1 DE 60133377D1 DE 60133377 T DE60133377 T DE 60133377T DE 60133377 T DE60133377 T DE 60133377T DE 60133377 D1 DE60133377 D1 DE 60133377D1
Authority
DE
Germany
Prior art keywords
present
prostheses
immunogenicity
vascular
valves
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60133377T
Other languages
English (en)
Other versions
DE60133377T2 (de
Inventor
Changyi Chen
Alan B Lumsden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baylor College of Medicine
Original Assignee
Baylor College of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College of Medicine filed Critical Baylor College of Medicine
Application granted granted Critical
Publication of DE60133377D1 publication Critical patent/DE60133377D1/de
Publication of DE60133377T2 publication Critical patent/DE60133377T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3625—Vascular tissue, e.g. heart valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005—Use of materials characterised by their function or physical properties
    • A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
DE60133377T 2000-04-28 2001-04-27 Dezellularisierte gefässprothesen Expired - Fee Related DE60133377T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20022000P 2000-04-28 2000-04-28
US200220P 2000-04-28
PCT/US2001/013617 WO2001082992A1 (en) 2000-04-28 2001-04-27 Decellularized vascular prostheses

Publications (2)

Publication Number Publication Date
DE60133377D1 true DE60133377D1 (de) 2008-05-08
DE60133377T2 DE60133377T2 (de) 2009-01-02

Family

ID=22740806

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60133377T Expired - Fee Related DE60133377T2 (de) 2000-04-28 2001-04-27 Dezellularisierte gefässprothesen

Country Status (8)

Country Link
US (2) US6689161B2 (de)
EP (1) EP1278559B1 (de)
JP (1) JP2003531685A (de)
AT (1) ATE390152T1 (de)
AU (2) AU5574101A (de)
CA (1) CA2407328A1 (de)
DE (1) DE60133377T2 (de)
WO (1) WO2001082992A1 (de)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001122791A (ja) * 1999-10-20 2001-05-08 Boehringer Ingelheim Internatl Gmbh 下肢の慢性静脈不全の軽減および予防のための赤色ブドウ樹葉の水性抽出物よりなる食事補強剤
AU2001284968B2 (en) * 2000-08-16 2006-12-21 Duke University Decellularized tissue engineered constructs and tissues
NL1019316C2 (nl) * 2001-11-06 2003-05-07 Tno Een vasculaire prothese.
US20040234575A1 (en) * 2002-05-09 2004-11-25 Roland Horres Medical products comprising a haemocompatible coating, production and use thereof
JP4092397B2 (ja) * 2002-09-10 2008-05-28 国立循環器病センター総長 超高静水圧印加による移植用生体組織の処理方法
US20040115176A1 (en) * 2002-10-23 2004-06-17 Swartz Daniel D. Fibrin-based tissue-engineered vasculature
US20040151769A1 (en) * 2002-12-31 2004-08-05 Boehringer Ingelheim International Gmbh Film coated tablet containing an extract of red vine leaves
US20040151794A1 (en) * 2002-12-31 2004-08-05 Boehringer Ingelheim International Gmbh Method of improvement of blood circulation
CN100358588C (zh) * 2003-03-31 2008-01-02 帝人株式会社 弹性蛋白成型体及其制备方法
US20050131520A1 (en) * 2003-04-28 2005-06-16 Zilla Peter P. Compliant blood vessel graft
US7998188B2 (en) * 2003-04-28 2011-08-16 Kips Bay Medical, Inc. Compliant blood vessel graft
ATE531338T1 (de) * 2003-04-28 2011-11-15 Kips Bay Medical Inc Elastisches venöses implantat
US20050288756A1 (en) * 2003-08-25 2005-12-29 Biophan Technologies, Inc. Medical device with an electrically conductive anti-antenna member
US20050125049A1 (en) * 2003-10-21 2005-06-09 The Regents Of The University Of Michigan Tissue engineered vascular construct and method for producing same
EP1550451A1 (de) * 2003-12-29 2005-07-06 Boehringer Ingelheim International GmbH Behandlung von chronischer venöser Insuffizienz mit einem Extrakt aus Blättern von roten Weinreben und einem Diuretika
EP1550450A1 (de) * 2003-12-29 2005-07-06 Boehringer Ingelheim International GmbH Behandlung von chronischer venöser Insuffizienz mit einem Extrakt aus Blättern von roten Weinreben und einem Blutumlauf verbesserndes Mittel
CA2551787C (en) * 2004-02-19 2014-04-08 Boehringer Ingelheim International Gmbh Composition for the treatment of chronic venous insufficiencies comprising an extract of red vine leaves and an anti-inflammatory agent
US7775965B2 (en) * 2004-03-09 2010-08-17 The Board Of Regents Of The University Of Oklahoma Decellularized grafts from umbilical cord vessels and process for preparing and using same
US20060282173A1 (en) * 2004-03-09 2006-12-14 Mcfetridge Peter S Substantially decellularized grafts from umbilical cord vessels and process for preparing and using same
EP1734814B1 (de) * 2004-03-17 2015-01-21 Revivicor, Inc. Gewebeprodukte aus tieren ohne jegliche expression einer funktionsfähigen alpha-1,3-galactosyltransferase
US8216299B2 (en) * 2004-04-01 2012-07-10 Cook Medical Technologies Llc Method to retract a body vessel wall with remodelable material
US7637937B2 (en) * 2004-04-08 2009-12-29 Cook Incorporated Implantable medical device with optimized shape
US9561309B2 (en) 2004-05-27 2017-02-07 Advanced Cardiovascular Systems, Inc. Antifouling heparin coatings
US7563276B2 (en) * 2004-10-29 2009-07-21 Cook Incorporated Intraluminal medical device with cannula for controlled retrograde flow
CA2612621C (en) * 2005-07-01 2014-11-18 Corline Systems Ab Heparin coating of biological tissue
CN1903143A (zh) * 2005-07-29 2007-01-31 广东冠昊生物科技有限公司 生物型人工血管及其制备方法
CN100482178C (zh) 2005-08-04 2009-04-29 广东冠昊生物科技有限公司 带生物膜的血管瘤夹
JP2009505752A (ja) 2005-08-26 2009-02-12 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ 臓器および組織の脱細胞化および再細胞化
US20100093066A1 (en) * 2005-08-26 2010-04-15 Regents Of The University Of Minnesota Decellularization and recellularization apparatuses and systems containing the same
WO2007070301A2 (en) * 2005-12-05 2007-06-21 Regeneration Technologies, Inc. Vascular graft sterilization and decellularization
CN1986006A (zh) * 2005-12-20 2007-06-27 广州知光生物科技有限公司 生物型神经导管
US7829108B2 (en) * 2006-04-21 2010-11-09 Wake Forest University Health Sciences Structurally modified acellular tissue engineering scaffolds and methods of production
US9114194B2 (en) 2006-05-12 2015-08-25 W. L. Gore & Associates, Inc. Immobilized biologically active entities having high biological activity following mechanical manipulation
US8986713B2 (en) * 2006-05-12 2015-03-24 W. L. Gore & Associates, Inc. Medical device capable of being compacted and expanded having anti-thrombin III binding activity
US20080279909A1 (en) * 2006-05-12 2008-11-13 Cleek Robert L Immobilized Biologically Active Entities Having A High Degree of Biological Activity Following Sterilization
US8021677B2 (en) 2006-05-12 2011-09-20 Gore Enterprise Holdings, Inc. Immobilized biologically active entities having a high degree of biological activity
US8496953B2 (en) * 2006-05-12 2013-07-30 W. L. Gore & Associates, Inc. Immobilized biologically active entities having a high degree of biological activity following sterilization
US20100023129A1 (en) * 2008-07-22 2010-01-28 Guo-Feng Xu Jawbone prosthesis and method of manufacture
CN101332314B (zh) * 2008-07-22 2012-11-14 广东冠昊生物科技股份有限公司 生物型关节软骨修补件
US8162815B2 (en) * 2007-01-16 2012-04-24 Mark Genovesi Method and device for preserving the vitality and function of a harvested blood vessel
WO2008097906A2 (en) * 2007-02-02 2008-08-14 The Regents Of The University Of Michigan System and method for forming bone, ligament and bone-ligament constructs
EP2178575A2 (de) * 2007-04-16 2010-04-28 Tissue Science Laboratories PLC Verfahren und zusammensetzungen zur geweberegeneration
US20100179639A1 (en) * 2007-04-16 2010-07-15 Stephen Bloor Vascular implant
EP2178576A2 (de) * 2007-04-16 2010-04-28 Tissue Science Laboratories PLC Knochenimplantat
US20080306610A1 (en) * 2007-06-07 2008-12-11 Zimmer Orthobiologics, Inc. Tissue processing for nonimmunogenic implants
EP2022511A1 (de) * 2007-08-06 2009-02-11 Corlife GbR Bioaktive Beschichtung für eine implantierbare Vorrichtung oder eine Bioprothese
WO2009044407A1 (en) * 2007-10-03 2009-04-09 International Centre For Cardio Thoracic And Vascular Diseases (A Unit Of Frontier Lifeline Pvt. Ltd) Small diameter vascular graft from processed cadaver saphenous vein
US7846199B2 (en) * 2007-11-19 2010-12-07 Cook Incorporated Remodelable prosthetic valve
US20090163990A1 (en) * 2007-12-19 2009-06-25 Chunlin Yang Decellularized omentum matrix and uses thereof
AU2009318772B2 (en) 2008-11-24 2016-05-19 The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center External stent
US8906362B2 (en) 2009-03-23 2014-12-09 Wake Forest University Health Sciences Tissue engineered meniscus scaffolds and methods of use
US8591932B2 (en) * 2009-09-17 2013-11-26 W. L. Gore & Associates, Inc. Heparin entities and methods of use
US8435305B2 (en) 2010-08-31 2013-05-07 Zimmer, Inc. Osteochondral graft delivery device and uses thereof
ES2562707T3 (es) 2010-09-01 2016-03-07 Regents Of The University Of Minnesota Métodos de recelularización de un tejido u órgano para una mejor capacidad de trasplante
CN102475919B (zh) * 2010-11-29 2015-04-29 吴忠仕 一种去细胞生物组织材料肝素涂层的制备方法
KR101933237B1 (ko) 2011-03-11 2018-12-27 더블유.엘. 고어 앤드 어소시에이트스, 인코포레이티드 고정화된 생물학적 실체의 개선
WO2012142569A2 (en) * 2011-04-15 2012-10-18 The Regents Of The University Of California Decellularized extracellular matrix
US10052218B2 (en) 2011-04-18 2018-08-21 Vascular Graft Solutions Ltd. Devices and methods for deploying implantable sleeves over blood vessels
US9290738B2 (en) 2012-06-13 2016-03-22 Miromatrix Medical Inc. Methods of decellularizing bone
US9125959B1 (en) * 2012-10-17 2015-09-08 University Of South Florida Compositions and methods for reducing or preventing medical device-related infections
US10058630B2 (en) 2012-10-22 2018-08-28 Concievalve, Llc Methods for inhibiting stenosis, obstruction, or calcification of a stented heart valve or bioprosthesis
KR102577616B1 (ko) 2013-03-15 2023-09-11 미로매트릭스 메디칼 인크. 섬 세포 재세포화를 위한 관류 탈세포화된 간의 용도
EP2787069B1 (de) * 2013-04-04 2015-08-05 Universität Leipzig Verfahren und Vorrichtung zur Dezellularisierung von Organen und Geweben
CA2912664C (en) * 2013-05-20 2022-07-26 Yale University Anti-thrombogenic grafts
CA2919374C (en) 2013-07-30 2019-12-03 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
CN110075355A (zh) * 2013-10-22 2019-08-02 康斯瓦维有限责任公司 用于抑制支架型心瓣膜或生物假体的狭窄、阻塞或钙化的方法
JP6515429B2 (ja) * 2013-12-16 2019-05-22 国立研究開発法人国立循環器病研究センター 人工血管、および、人工血管の製造方法
WO2016143746A1 (ja) * 2015-03-12 2016-09-15 一般財団法人化学及血清療法研究所 脱細胞化組織を用いた癒着防止材及び代用生体膜
US10912864B2 (en) 2015-07-24 2021-02-09 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US11052175B2 (en) 2015-08-19 2021-07-06 Musculoskeletal Transplant Foundation Cartilage-derived implants and methods of making and using same
CA3003069A1 (en) 2015-11-02 2017-05-11 VeriGraft AB Compositions and methods for healing wounds
US11278643B2 (en) 2016-09-06 2022-03-22 Mayo Foundation For Medical Education And Research Use of resected liver serum for whole liver-engineering
WO2018102826A1 (en) * 2016-12-02 2018-06-07 Vascudyne, Llc Engineered tissue prosthesis
RU2736480C2 (ru) * 2018-05-15 2020-11-17 Федеральное государственное бюджетное образовательное учреждение высшего образования "Бурятский государственный университет имени Доржи Банзарова" Способ производства коллаген-ламининового матрикса для заживления язв, ожогов и ран кожи человека
LT3830243T (lt) * 2018-08-03 2023-08-25 VeriGraft AB Individualizuotų kraujagyslių paruošimo metodai
CN112274699A (zh) * 2019-07-24 2021-01-29 西安交通大学医学院第一附属医院 小口径组织改良复合型人工血管
EP4104863A4 (de) * 2020-02-14 2024-02-21 Kheiros Pater Inovacao S A Verfahren zur herstellung von dezellularisiertem biomaterial, dezellularisiertes biomaterial und verwendung davon
CN114306747A (zh) * 2021-12-29 2022-04-12 中国人民解放军陆军军医大学 一种小口径心血管植入物及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4034750A (en) 1975-04-22 1977-07-12 Maurice Seiderman Electrochemically linking collagen fibrils to animal tissue
US4798606A (en) 1985-02-26 1989-01-17 Corvita Corporation Reinforcing structure for cardiovascular graft
US4795741A (en) 1987-05-06 1989-01-03 Biomatrix, Inc. Compositions for therapeutic percutaneous embolization and the use thereof
US5475052A (en) 1988-11-21 1995-12-12 Collagen Corporation Collagen-synthetic polymer matrices prepared using a multiple step reaction
US5336616A (en) 1990-09-12 1994-08-09 Lifecell Corporation Method for processing and preserving collagen-based tissues for transplantation
US5275826A (en) 1992-11-13 1994-01-04 Purdue Research Foundation Fluidized intestinal submucosa and its use as an injectable tissue graft
KR100365573B1 (ko) * 1994-03-14 2004-08-25 크라이어라이프, 인크. 이식용처리조직및이의제조방법
US5716394A (en) 1994-04-29 1998-02-10 W. L. Gore & Associates, Inc. Blood contact surfaces using extracellular matrix synthesized in vitro
US6121041A (en) * 1996-07-31 2000-09-19 St. Jude Medical, Inc. Use of microorganisms for decellularizing bioprosthetic tissue
JP2001520542A (ja) 1997-04-11 2001-10-30 クライオライフ・インコーポレーテッド 組織の無細胞化
US5958669A (en) 1997-05-02 1999-09-28 St. Jude Medical, Inc. Apparatus and method for crosslinking to fix tissue or crosslink molecules to tissue
US5910170A (en) * 1997-12-17 1999-06-08 St. Jude Medical, Inc. Prosthetic heart valve stent utilizing mounting clips
CA2358565A1 (en) 1999-01-22 2000-07-27 Peter S. Dardi Medical adhesives
US6387116B1 (en) * 1999-06-30 2002-05-14 Pharmasonics, Inc. Methods and kits for the inhibition of hyperplasia in vascular fistulas and grafts
US20020077697A1 (en) * 2000-12-15 2002-06-20 Ranieri John Paul Processed ratite carotid arteries as xenogeneic small bore vascular grafts

Also Published As

Publication number Publication date
AU5574101A (en) 2001-11-12
CA2407328A1 (en) 2001-11-08
DE60133377T2 (de) 2009-01-02
EP1278559B1 (de) 2008-03-26
US20010044654A1 (en) 2001-11-22
US6689161B2 (en) 2004-02-10
ATE390152T1 (de) 2008-04-15
AU2001255741B2 (en) 2005-08-04
US7060022B2 (en) 2006-06-13
JP2003531685A (ja) 2003-10-28
EP1278559A1 (de) 2003-01-29
US20040137618A1 (en) 2004-07-15
WO2001082992A1 (en) 2001-11-08

Similar Documents

Publication Publication Date Title
ATE390152T1 (de) Dezellularisierte gefässprothesen
US6395023B1 (en) Prosthesis with biodegradable surface coating and method for making same
Sauvage et al. Future directions in the development of arterial prostheses for small and medium caliber arteries
US6440166B1 (en) Multilayer and multifunction vascular graft
Bui et al. Renal artery aneurysm: treatment with percutaneous placement of a stent-graft.
WO2003045467A3 (en) Intraluminal prosthesis attachment systems and methods
ES2166885T3 (es) Procedimiento de fabricacion de injertos vasculares tubulares.
CA2342640A1 (en) Hernia repair prosthesis
WO2005034852A3 (en) Protein biomaterials and biocoacervates and methods of making and using thereof
DE60239878D1 (de) Sich selbst stützende implantierbare metallprothesen
DE69832616D1 (de) Verwendung von hyaluonsäurederivaten zur herstellung von biomaterial
Kenney et al. Comparison of noncrimped, externally supported (EXS) and crimped, nonsupported Dacron prostheses for axillofemoral and above-knee femoropopliteal bypass
IL153946A0 (en) Artificial vascular grafts, and methods of producing and using same
Herring et al. Patency in canine inferior vena cava grafting: effects of graft material, size, and endothelial seeding
Kato et al. Experimental assessment of newly devised transcatheter stent-graft for aortic dissection
JPH11502734A (ja) 親水性ポリマー組成物で処理された医療機器
Hiratzka et al. Experimental and clinical results of grafts in the venous system: a current review
Nojiri et al. Aorta-coronary bypass grafting with heparinized vascular grafts in dogs: a preliminary study
Richardson et al. The role of endothelium in the patency of small venous substitutes
Van Der Lei et al. Microarterial grafting into the carotid artery of the rabbit: some considerations concerning species-dependent thrombogenicity
US9345808B2 (en) Structure having fibres which are adhesively bonded to one another in locations
Robinson et al. Patency and healing of polymeric microvenous prostheses implanted into the rat femoral vein by means of the sleeve anastomotic technique
Nemes et al. Application of a vascular graft material (Solcograft®-P) in experimental surgery
Norgren et al. Experimental evaluation of polymerized Dacron grafts in the iliac position of pigs
Steinhart et al. Preformation of microvascular composite free flaps in the rat as an animal model

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee